SkinTwo labels compared
Clindamycin with benzoyl peroxide vs adapalene
These are two topical treatments for the same condition that a person meets in two different places: one at a pharmacy counter with a prescription, the other on a shelf. The documents behind them are written for different readers, and one of them carries a contraindication that has nothing to do with skin.
Clindamycin and benzoyl peroxide gel
- Approved for
- Acne vulgariscovers skin
- Supply
- Prescription
- Boxed warning
- None
- Pharmacy cost
- $0.671 per gram, genericwhat pharmacies pay to buy it, not the price at the counter
Differin gel
- Ingredient
- Adapalene
- Approved for
- Acnecovers skin
- Supply
- Over the counter
- Boxed warning
- None
- Pharmacy cost
- $11.27 per gram, brandwhat pharmacies pay to buy it, not the price at the counter
Side by side, straight from the labels
Generated from the two source labels, not typed out by hand, so it cannot drift from what the regulator approved. Rows where both labels say exactly the same thing are marked.
| Label section | Clindamycin and benzoyl peroxide gelClindamycin phosphate and benzoyl peroxide | Differin gelAdapalene |
|---|---|---|
| Active ingredient | Clindamycin and benzoyl peroxide gelClindamycin phosphate and benzoyl peroxideTopical antibacterial combination | Differin gelAdapaleneTopical retinoid |
| Approved for | Clindamycin and benzoyl peroxide gelAcne vulgaris | Differin gelAcne |
| Supply | Clindamycin and benzoyl peroxide gelPrescription | Differin gelOver the counter |
| What pharmacies payAcquisition cost, not retail | Clindamycin and benzoyl peroxide gel$0.671 per gram, generic | Differin gel$11.27 per gram, brand |
| Boxed warningsame in both | Clindamycin and benzoyl peroxide gelNone | Differin gelNone |
| What the FDA approved it for | Clindamycin and benzoyl peroxide gel
| Differin gel
|
| Forms and strengths | Clindamycin and benzoyl peroxide gel
| Differin gel
|
| How the label says it is taken | Clindamycin and benzoyl peroxide gel
| Differin gel
|
| Most common adverse reactions | Clindamycin and benzoyl peroxide gel
| Differin gel
|
| Warnings and precautions | Clindamycin and benzoyl peroxide gel
| Differin gel
|
| Contraindications | Clindamycin and benzoyl peroxide gel
| Differin gel
|
| Drug interactions | Clindamycin and benzoyl peroxide gel
| Differin gel- |
| Label version | Clindamycin and benzoyl peroxide gel15 August 2025 | Differin gel7 December 2022 |
Both treat acne, and one of them contains an antibiotic
The clindamycin and benzoyl peroxide gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older, and its label describes it as a combination of clindamycin phosphate, a lincosamide antibacterial, with benzoyl peroxide. The Differin gel label, written in the Drug Facts format used for products sold without a prescription, gives its use simply as the treatment of acne and names the active ingredient as adapalene 0.1 percent, a retinoid.
Only one of the two contains an antibiotic, and that single difference accounts for most of what follows.
The contraindication that is not about skin
The prescription gel is contraindicated in people with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis, alongside hypersensitivity to clindamycin, to benzoyl peroxide, to any component of the formulation, or to lincomycin.
A bowel condition appearing in the contraindications of a gel applied to the face is worth pausing on. It is there because of the clindamycin component, and it is the kind of thing that a prescription document records and a shelf product does not have to.
The Differin label instead tells the buyer directly what to avoid: do not use on damaged skin, meaning cuts, abrasions, eczema or sunburn, and do not use if allergic to adapalene or to any of the ingredients.
The prescription label records antibiotic resistance
The clindamycin and benzoyl peroxide label states that resistance of the bacterium associated with acne to clindamycin has been documented, and that resistance to clindamycin is often associated with resistance to erythromycin. It also directs that the gel be avoided in combination with topical or oral erythromycin-containing products, because of its clindamycin component.
Nothing equivalent appears in the adapalene label, because there is no antibiotic in it to resist.
Both are applied once a day, and the instructions differ in tone
The prescription label gives a pea-sized amount to the face once daily. The Drug Facts label tells the buyer to clean the skin gently and pat dry first, then cover the entire affected area with a thin layer, and adds that applying more than once a day will not give faster or better results but may worsen irritation.
That last sentence has no counterpart in the prescription document, and it exists because nobody is standing between the buyer and the tube.
What this page does not tell you
It does not say which one a person should use, and the fact that one can be bought without a prescription does not make that choice unimportant. The full lists of warnings and reported adverse reactions from each label are reproduced on the individual pages.
Common questions
- Why does a face gel warn about bowel conditions?
- Because of the clindamycin in it. The label contraindicates use in people with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. This page reports that the contraindication exists; it does not explain the reasoning, which the label does not set out.
- Is the prescription one stronger?
- The two were not studied against each other and neither label compares itself to the other. They contain different active ingredients and work by different routes, so there is no comparison of strength to report.
- Can they be used together?
- Neither label describes using the two together. The prescription label does state that its gel should be avoided in combination with erythromycin-containing products, which is a different question. Combining treatments is a decision for a clinician.
Sources
Every fact above comes from one of these documents. The date is the effective date of the label version this page was built from.
FDA prescribing information for Clindamycin and benzoyl peroxide gel
Oceanside Pharmaceuticals. Label version 6, effective 15 August 2025.
FDA prescribing information for Differin gel
Galderma Laboratories, L.P.. Label version 10, effective 7 December 2022.
Each stripe is one section of the label, each division in a stripe one entry in that section.
Other comparisons in this category
Page last updated 23 August 2026
Compiled by the HealthyStudy editorial team from FDA source documents. No medical reviewer is credited on this page, because none reviewed it.